Figure 2 | Scientific Reports

Figure 2

From: 99mTc-labeled bevacizumab for detecting atherosclerotic plaque linked to plaque neovascularization and monitoring antiangiogenic effects of atorvastatin treatment in ApoE−/− mice

Figure 2

The stability, pharmacokinetics and biodistributions results of 99mTc-MAG3-bevacizumab. (a–b) In-vitro stability test of the probe incubated in 0.9% NaCl, PBS and serum solution at room temperature or 37 °C. c, Pharmacokinetics of 99mTc-MAG3-bevacizumab. e, Biodistribution results at 2 h, 5 h and 12 h post injection of the tracer. Abbreviation: PBS, phosphate buffered solution; %ID/g, percent injected dose per gram tissue.

Back to article page